MedTrace Logo

Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

NCT02217228 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 394

Last updated 2017-09-18

No results posted yet for this study

Summary

Prospective, randomized multicenter study to examine the safety and effectiveness of Sebacia microparticles with or without laser in the treatment of moderate to moderately-severe inflammatory acne vulgaris

Conditions

  • Inflammatory Acne Vulgaris

Interventions

DEVICE

Sebacia microparticles and laser

DEVICE

Vehicle suspension and laser

DEVICE

Sebacia microparticles without laser

Sponsors & Collaborators

  • Sebacia, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02217228 on ClinicalTrials.gov